Citation Impact
2 from Science/Nature 80 standout
Citing Papers
Overall survival with sacituzumab govitecan in hormone receptor-positive and human epidermal growth factor receptor 2-negative metastatic breast cancer (TROPiCS-02): a randomised, open-label, multicentre, phase 3 trial
2023 Standout
Recent Advances in Hyperthermia Therapy‐Based Synergistic Immunotherapy
2020 Standout
Works of C Vogel being referenced
First line, non-hormonal treatment of women with HER2 overexpressing metastatic breast cancer with herceptin (trastuzumab, humanized anti-HER2 antibody)
2000
Randomized comparison of vinorelbine and melphalan in anthracycline-refractory advanced breast cancer.
1995
Author Peers
| Author | Oncology | PRM | RNMI | Cancer Research | Last Decade | Papers | Cites |
|---|---|---|---|---|---|---|---|
| C Vogel | 295 | 54 | 64 | 124 | 8 | 324 | |
| Geeta Iyer | 11 | 3 | 8 | 3 | 8 | 384 | |
| Xiaojun Fang | 128 | 15 | 11 | 40 | 19 | 560 | |
| João Felipe Peres Rezer | 8 | 15 | 1 | 6 | 24 | 446 | |
| Haruyo Iwadate | 26 | 24 | 10 | 3 | 25 | 308 | |
| Fabien Cousin | 22 | 23 | 11 | 5 | 21 | 1.2k |
All Works
Loading papers...